Pharmaceuticals

Premium

Healthcare

18 December, 2023

InvAscent hits first close for new healthcare fund; strikes back-to-back PE deal

Homegrown healthcare-focussed private equity fund InvAscent has hit the first close for its latest vehicle, even as it ......

Premium

Healthcare

24 July, 2023

Advent may rope in new investor for Bharat Serums with neat valuation markup

Mumbai-based biopharmaceutical company Bharat Serums, controlled by private equity major Advent International, is ......

Premium

Finance

04 May, 2023

Zydus promoters eye $200 mn from sale of private clinical research biz

Zydus Group is exploring the sale of its clinical research business, Cliantha Research Ltd, in a deal that could ......

Premium

Healthcare

21 April, 2023

Investors turn towards healthcare as sector yields major exits in 2022

The last year was an unprecedented scenario for PE/VC players in India as well as the world. While the country ......

Premium

Healthcare

11 April, 2023

Glenmark revives API biz sale after stock crumbles

Glenmark Pharmaceuticals Ltd is considering selling a majority stake in Glenmark Life Sciences to pare debt, said two ......

Premium

Healthcare

23 April, 2021

French firm Sanofi looks to sell select non-core drugs to local pharma company

Sanofi India Ltd, local unit of the French drugmaker, is in advanced discussions to sell a non-core portfolio of drugs ......

Premium

Healthcare

01 March, 2021

Gujarat pharma firm to hit the rocks three years after bankruptcy

A Vadodara-based pharmaceuticals company, which entered insolvency three years ago, will collapse into liquidation as the apex...

Premium

Healthcare

15 October, 2020

Economic Law Practice's Suhail Nathani joins conglomerate board

Suhail Nathani, managing partner at Economic Law Practice (ELP), has joined one of India’s top conglomerates as a director...

Premium

Healthcare

07 February, 2018

Drugmaker among others in talks for Series C funding in PharmEasy

Mumbai-headquartered 91 Streets Media Pvt. Ltd, which operates online drug delivery platform PharmEasy, is planning to raise its Series C ......

Premium

Healthcare

04 September, 2017

Company watch: Concord Biotech eyes new opportunities after Quadria's backing

Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20 years ago to start his entrepreneurial journey. The Ahmedabad-based biotechnology ......

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News